Sangamo Therapeutics Inc Sustainability Reports
Sangamo Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on translating ground-breaking science into genomic medicines. The company utilizes its proprietary zinc finger genome engineering technology to develop treatments for genetic diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 2549006WMRKRC4G32Z67
FIGI: BBG001S95JZ2
3 reports from 2019 to 2021